Controlled Cord Traction During Third Stage of Labor
CCT
3 other identifiers
interventional
200
1 country
2
Brief Summary
Of the estimated number of 529,000 maternal deaths for the year 2000, 132,000 (25%) were caused by postpartum hemorrhage (PPH); 99% of these deaths occurred in low-income countries. Where maternal mortality is high and resources are limited, the introduction of low-cost, evidence-based practices for primary prevention of PPH is an urgent need. Controlled cord traction (CCT) is actively promoted in combination with prophylactic uterotonics for the prevention of PPH. While the administration of uterotonics has been proven effective, there is no evidence of CCT being beneficial or safe. The investigators propose this study to evaluate two primary questions:
- 1.In women having term, single vaginal deliveries in hospital settings, in whom the third stage is managed with prophylactic oxytocin, does CCT produce a clinically significant reduction in the incidence of postpartum blood lose?
- 2.In these women, does CCT produce a clinically significant increase in the incidence of severe complications, including uterine inversion or the need for subsequent surgical evacuation of retained placental tissues and membranes (curettage or manual removal)?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Jan 2007
Shorter than P25 for phase_3
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2007
CompletedFirst Submitted
Initial submission to the registry
October 27, 2008
CompletedFirst Posted
Study publicly available on registry
October 28, 2008
CompletedOctober 28, 2008
October 1, 2008
8 months
October 27, 2008
October 27, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postpartum blood loss
a minimum of 20 minutes after delivery
Secondary Outcomes (5)
Manual removal of placenta
within 1 hour after delivery
Uterine inversion
within 30 minutes after delivery
Uterine curettage
before hospital discharge
Blood transfusion
before Hospital discharge
Length of third stage of labor (minutes)
until expulsion of the placenta
Study Arms (2)
1
EXPERIMENTALControlled cord traction (CCT)
2
ACTIVE COMPARATORNo CCT
Interventions
1. Clamp the cord close to the perineum (once pulsation stops, or after three minutes in a healthy newborn), hold it in one hand. 2. Place the other hand just above the woman's pubic bone and stabilize the uterus by applying counter-pressure during controlled cord traction. 3. Keep slight tension on the cord and await a strong uterine contraction (2-3 minutes). 4. With the strong uterine contraction, encourage the mother to push and very gently pull downward on the cord to deliver the placenta. Continue to apply counter-pressure to the uterus. 5. If the placenta does not descend during 30-40 seconds of CCT, do not continue to pull on the cord: * Gently hold the cord and wait until the uterus is well contracted again; * With the next contraction, repeat CCT with counter-pressure.
1. Clamp the cord close to the perineum (once pulsation stops, or after three minutes in a healthy newborn). 2. No CCT will be used and no fundal pressure. The placenta will be delivered physiologically, and signs for placental separation will be awaited (gush of blood from the vagina, descent of the umbilical cord, and increase in the height of the uterus in the abdomen as the lower segment was distended). 3. After separation, delivery of the placenta will be aided only by maternal expulsive efforts and/or gravity.
Eligibility Criteria
You may qualify if:
- years old or more
- Single pregnant women during third trimester of prenatal care or in early first stage of labor at the participating hospital (Cervical dilatation ≤ 6 cm).
- No indication of cesarean section
- No contraindications for receiving prophylactic uterotonics
- Gestational age ≥ 37 weeks
- Imminent vaginal delivery
You may not qualify if:
- Severe acute complications during labor requiring emergency actions (e.g., eclampsia, hemorrhage, or any other complications that imply serious difficulties according to the judgment of the attendant)
- No consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Clinica's Hospital Manuel Quintela of the University of the Republic of Uruguay
Montevideo, Montevideo Department, 11600, Uruguay
Pereira Rossell Hospital
Montevideo, Montevideo Department, 11600, Uruguay
Related Publications (2)
Carvalho JF, Piaggio G, Wojdyla D, Widmer M, Gulmezoglu AM. Distribution of postpartum blood loss: modeling, estimation and application to clinical trials. Reprod Health. 2018 Dec 4;15(1):199. doi: 10.1186/s12978-018-0641-1.
PMID: 30514326DERIVEDPiaggio G, Carvalho JF, Althabe F. Prevention of postpartum haemorrhage: a distributional approach for analysis. Reprod Health. 2018 Jun 22;15(Suppl 1):97. doi: 10.1186/s12978-018-0530-7.
PMID: 29945633DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alicia V Aleman, MD
Unidad de Investigación Clínica y Epidemiológica Montevideo
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 27, 2008
First Posted
October 28, 2008
Study Start
January 1, 2007
Primary Completion
September 1, 2007
Study Completion
September 1, 2007
Last Updated
October 28, 2008
Record last verified: 2008-10